enow.com Web Search

  1. Ads

    related to: fda approved skin substitutes for dogs prescription diet treatment program

Search results

  1. Results from the WOW.Com Content Network
  2. US FDA approves Elanco's skin disease treatment for dogs - AOL

    www.aol.com/news/us-fda-approves-elancos-skin...

    The FDA approval for Zenrelia carries a boxed warning stating that dogs should not be vaccinated at least 28 days before and after treatment with the drug, due to the risk of fatal vaccine-induced ...

  3. Dirlotapide - Wikipedia

    en.wikipedia.org/wiki/Dirlotapide

    Dirlotapide is used to manage obesity in dogs and helps by reducing appetite. It is used as part of an overall weight control program that also includes proper diet and exercise, under the supervision of a veterinarian. Side effects may include vomiting, diarrhea, lethargy, drooling, or uncoordination.

  4. Skin conditions in dogs: Symptoms, causes, and how to help - AOL

    www.aol.com/skin-conditions-dogs-symptoms-causes...

    The dog then causes further trauma to the skin by itching and rubbing at the area, leading to a secondary bacterial infection." Acute moist dermatitis: Symptoms A patch of moist, inflamed skin ...

  5. FDA Approves APOQUEL® (oclacitinib tablet) to Control Itch ...

    www.aol.com/news/2013-05-16-fda-approves-apoquel...

    In a clinical trial of dogs with atopic dermatitis, treatment success for pruritus occurred in a significantly greater percentage of the dogs treated with APOQUEL (66 percent) vs. (4 percent) of ...

  6. Tigilanol tiglate - Wikipedia

    en.wikipedia.org/wiki/Tigilanol_tiglate

    Tigilanol tiglate (USAN; [1]), sold under the brand name Stelfonta is a medication used to treat dogs with non-metastatic, skin-based mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog's skin (subcutaneous), in particular areas of a dog's leg. [2]

  7. Oclacitinib - Wikipedia

    en.wikipedia.org/wiki/Oclacitinib

    Most of the other contraindications are avoiding cases where a potential side effect exacerbates a pre-existing condition: for example, because oclacitinib can cause lumps or tumors, it should not be used in dogs with cancer or a history of it; [15] because it is an immune system suppressant, it should not be used in dogs with serious infections.

  1. Ads

    related to: fda approved skin substitutes for dogs prescription diet treatment program